Neuro-Oncology News

The prospect of screening for multiple cancer types simultaneously through a blood draw or other simple methods has generated tremendous excitement.

May is Brain Tumor Awareness Month.

AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

A phase 1 trial showed chimeric antigen receptor T-cell therapy may hold promise for the treatment of glioblastoma.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.

The FDA granted accelerated approval to Ojemda for the treatment of certain children with relapsed or refractory low-grade glioma.

An innovative combination of drug sensitivity testing and genomics helped identify therapeutic options for children with relapsed or refractory solid or hematologic malignancies, according to results published in Nature Medicine.

The prolonged use of certain progestogen hormone drugs — such as medrogestone, medroxyprogesterone acetate and promegestone — increased the risk for developing intracranial meningioma, according to data published in The BMJ.

Parents of children with cancer made mental health visits, including those for anxiety and depression, significantly more often than other parents, according to results published in JAMA Network Open.